ClinicalTrials.govpublic full text
Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older
epilepsy, monotherapy, lacosamide, vimpat®, velocity, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832753
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.